»Call Us 336-396-3916


July 12, 2019
Print page

Brakke Consulting’s
Animal Health News & Notes for July 12, 2019
Copyright © Brakke Consulting

Editor: Lynn Fondon DVM MBA

Brakke Consulting news
Market research reports

other news
Animal Ethics
Brookside Agra
Calidi Biotherapeutics
Kinetic Vet
Lallemand Animal Nutrition
Medivet Group
NH Foods
Northern Private Capital
NovoBind Livestock Therapeutics
Oasmia Pharmaceutical
Perrigo Animal Health
Pet Supplies Plus
Premier Veterinary Group
VetStem Biopharma
WIKI Group

Southwest Veterinary Symposium
San Antonio, Texas at the Henry B. Gonzalez Convention Center

September 26-29, 2019

Early Bird Registration ends July 18th !

“Unleash Your Career”

Southwest Veterinary Symposium — a partnership of the Arkansas, Louisiana, New Mexico, Oklahoma and Texas Veterinary Medicine Associations which provides continuing education for veterinary professionals. Join us this September in San Antonio, Texas where you can learn about the latest innovations and products, network with other veterinary professionals, explore design and renovation ideas and choose from more than 390 hours of quality courses.



• Bayer has reportedly approached Elanco Animal Health to discuss a possible combination of their pet-health businesses, three sources familiar with the matter have told Reuters. According to the sources, speaking on condition of anonymity, the two companies are working with banks to ensure any merger would secure regulatory approval. Bayer has reportedly delayed the launch of an auction to private equity funds to pursue the merger; an auction process was initially expected to start in June but Bayer is now planning to send information packages to prospective bidders towards the end of the summer. (Reuters)

• The FDA announced it has approved Huvepharma’s Monovet 90 Type A medicated article, the first generic monensin for use in cattle and goats for certain indications. (FDA)

• Phibro Animal Health Corporation announced it is pursuing patent protection following a significant advance in the on-going development of a vaccine for African Swine Fever (ASF). The patent involves the identification of immunogenic epitopes and proteins that show strong potential to form the basis for a vaccine against ASF. Phibro’s approach is to create a specific epitope-based vaccine, rather than following the more conventional path of an attenuated live vaccine. If successful, this approach would not only be an effective response to ASF but would result in a vaccine that presents no risk of further spreading the disease. (company press release)

• Bimeda Animal Health announced it received FDA approval for generic injectable treatments for OxyMed LA (generic oxytetracyline injection) in cattle and swine; and EnroMed 100 (generic enrofloxacin injectable solution) for cattle and swine. (Animal Pharm)

• Oasmia Pharmaceutical has put plans to publicly list its US subsidiary AdvaVet on hold, aiming to regain full control over its intellectual property rights for veterinary applications. The firm is undertaking a review of issues related to its patents and taxes, and a new board will be installed “to review all value-generating options for Oasmia in the veterinarian oncology field, as well as AdvaVet’s planned organization and current cost structure”. (Animal Pharm)

• Kinetic Vet announced the availability of the AmTech Large Animal I.V. Coil Set. Designed for large animals, the AmTech I.V. Coil Set is a new, ten foot polyurethane coil that delivers 28 liters of fluid per hour by gravity and allows simultaneous administration of drugs, plasma, blood and electrolytes with a quick, easy set-up. (company press release)

• PetIQ, Inc. announced that it has completed the previously announced acquisition of Perrigo Animal Health from Perrigo Company plc for $185 million in cash. The transaction was financed through a combination of $25 million of existing cash on hand, $145 million of new term loan financing from Ares Capital Management, with the remaining balance financed through PetIQ’s existing revolving credit facility. (company press release)

• Brookside Agra announced the launch of Brook-Lytes — a non-medicated, pH-buffered electrolyte for pigs of all stages and environments. When added to drinking water, Brook-Lytes draws pigs to drink with its highly palatable formula and unique aromatic flavor to keep them hydrated and fortified with essential nutrients. (Feedstuffs)

• VetStem Biopharma announced an exclusive global license to Calidi Biotherapeutics’ immunotherapy for the development of a pet cancer treatment. Calidi is developing biotechnology for stem cell-based delivery of oncolytic virus-based immunotherapies for human cancer; its lead candidate is SuperNova1, which is currently in phase II clinical trials in humans. (Animal Pharm)

• Pet Supplies Plus announced it is recalling bulk pig ear product supplied to all locations by several different vendors due to the potential of Salmonella contamination. Bulk pig ears were stocked in open bins; prepackaged branded pig ears are not included in this voluntary recall. (Petfood Industry)

• Dogtopia announced that it has opened its 100th dog daycare center in Deer Park, Illinois. The franchise company has seen a 35% increase in store numbers over the course of one year, and a 300% increase since current ownership and management took control of the company in 2015; another 250 locations are in the pipeline. (Vet Advantage – Pet Product News)

• AUSTRALIA Dechra Pharmaceuticals announced it has acquired a further 15% of the issued share capital of Medical Ethics, the parent company of Animal Ethics, for a total consideration of A$13.5 million (US$9.4 million). Following the acquisition Dechra will own 48% of the issued share capital of Medical Ethics. Animal Ethics is developing the livestock analgesic Tri-Solfen. (Sharecast.com)

• CANADA Lallemand Animal Nutrition announced an R&D collaboration with NovoBind Livestock Therapeutics to scale-up production of NovoBind’s Salmonella biologic, as well as conduct in vivo trials. The biologic is based on single domain antibody fragments. Additionally, Lallemand will make a strategic minority investment in the company, with the funding a part of NovoBind’s ongoing series A round. (Animal Pharm)

• EU BioZyme Inc. announced that WIKI Group is its newest international partner and will provide Amaferm and AO-Ferm prebiotics to its customers throughout France, Portugal and Spain. (Feedstuffs)

• UK Premier Veterinary Group PLC announced it has signed a two-year contract with UK veterinary firm Medivet Group Ltd up until September 2021. Under the agreement, Premier Veterinary’s subsidiary Premier Vet Alliance Ltd will support The Medivet Healthcare Plan in the UK, by supplying its proprietary portal and technology platform. This new contract builds on the relationship between Premier and Medivet which started in 2013. (Morningstar.co.uk)

• JAPAN NH Foods (formerly Nippon Meat Packers) announced the Japanese launch of NH Immunostick Foot-and-Mouth Disease, a diagnostic for foot-and-mouth disease. Japan was declared free of FMD by the OIE in 2011 following an outbreak in 2010. (Animal Pharm)

• CANADA MicroSintesis, a startup focused on developing proprietary microbiome therapies for livestock, companion animal and human health, announced the closure of a $16.4 million minority investment from Northern Private Capital (NPC), an investment vehicle of CFFI Ventures. The funding will be used to scale up production of the company’s products and build out its research capabilities and platform. (Feedstuffs)


• US – SALMONELLA OUTBREAK The CDC, public health and regulatory officials in several states and the FDA are investigating a multi-state outbreak of multi-drug-resistant salmonella infections linked to contact with pig ear dog treats. As of July 2, 2019, CDC reported that a total of 45 infected people from 13 states have been reported. Epidemiologic evidence indicates that contact with pig ear dog treats is the likely source of this outbreak. (Feedstuffs)

• IRELAND – ASF Meat infected by African swine fever virus was discovered in the United Kingdom for the first time when officials detected the virus in processed meat seized by port authorities from the luggage of airport passengers in Northern Ireland. The ASF virus can live in processed meats for months, according to officials, but discovery of “DNA fragments” of the virus does not constitute a significant health threat to Northern Ireland’s animals, and does not affect the country’s disease-free status. (interestingengineering.com)

• US – VESICULAR STOMATITIS Horses in three states — Colorado, New Mexico, and Texas — have tested positive for vesicular stomatitis (VS), according to the USDA Animal and Plant Health Inspection Service (APHIS). Because of the virus’ contagious nature and its resemblance to other diseases such as foot-and-mouth disease, animal health officials urge livestock owners and caretakers to report these symptoms to their veterinarian immediately. (TheHorse.com)

• US – VETERINARY CARE California’s newly adopted state budget, which went into effect last week, includes $5 million in grants to fund veterinary and other care for pets of homeless people. The money will help place veterinarians at qualified homeless shelters, allowing those living on the streets to access care for their pets. (fox8.com)


Brakke Consulting is an industry leader in timely market research on topics of high interest to stakeholders in the animal health, pet and veterinary markets. Reports published in the past two years include:

• Pain Management Products for Dogs and Cats (May 2019)
• Field Sales and Veterinary Teams (January 2019)
• US Flea Control and Heartworm Markets (December 2018)
• Manufacturer Sales Force Effectiveness Study (December 2018)
• The Companion Animal Veterinary Telehealth Landscape (October 2018)
• Veterinary Practice Home Delivery (May 2018)
• Veterinary Technical Services Study (March 2018)
• Equine Mega Study IV (January 2018)
• Distributor Effectiveness Study (December 2017)
• Cancer in Dogs and Cats (October 2017)

Prices for reports vary. For more information about these or other reports, visit our website at https://www.brakkeconsulting.com/our-services/information/multi-client-studies/ or contact us at info@BrakkeConsulting.com.



Real “M”

The livestock-oriented animal health press has been inundated this past year with articles about foods designed to replace the protein consumers have traditionally obtained from eating meat. These alternative protein sources have been variously named, but I am resolved not to refer to them using the “M” word. Many of the foods are plant based and of course, the newer ones derived from cultured animal cells are frequently referred to as lab-grown or cultured. I am not opposed to the consumption of these protein sources or companies that promote them, I just wish they would carve out their own space without denigrating the virtues of “real” meat.

The potential of the alternative protein marketplace has not gone unnoticed by big meat purveyors. They have invested and I believe they will continue to invest heavily in the segment to insure their position as protein providers of the future. I expect to see alternative protein options appearing soon in most, if not all, of the large chain fast food establishments. Why? It was explained to me as “the minority rules”. For example, if you are going out to eat and one of your party prefers alternative protein food, the balance of the party is likely to respect their wishes and select a location with that option. Without the option it is not a lost meal. It is a lost party of meals.

However, all has not gone the way of alternative protein. Last week at the annual Coney Island hot dog eating championship, Joey Chestnut downed 71. The National Hot Dog & Sausage Council says Americans consumed 150 million hot dogs to celebrate the Fourth of July. Yes, I still consider hot dogs as part of the “M” realm. Please pass the mustard!

Cary Christensen

This electronic newsletter is the sole property of Brakke Consulting.
Any use of the contents herein should be approved by and appropriately attributed to Brakke Consulting.

For more information about Brakke Consulting’s services and syndicated studies, visit our website at www.brakkeconsulting.com.

Brakke Consulting
806 Green Valley Rd
Suite 200
Greensboro, NC 27408